Effect of Black Tea and Black Tea Pomace Polyphenols on α-Glucosidase and α-Amylase Inhibition, Relevant to Type 2 Diabetes Prevention

Frontiers in Nutrition

Volumn 2, Issue , 2015, Pages

  Striegel, Lisa ^a,b   Kang, Bouhee ^a   Pilkenton, Sarah J ^a   Rychlik, Michael ^b   Apostolidis, Emmanouil ^a  

^a FRAMINGHAM STATE UNIVERSITY   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

black tea; black tea pomace; phenolic compounds; pre diabetes; type 2 diabetes; amylase inhibition; glucosidase inhibition

Indexed keywords

EID: 84928167953     PISSN: None     EISSN: 2296861X     Source Type: Journal    
DOI: 10.3389/fnut.2015.00003     Document Type: Article

References (21)

1. IDF (International Diabetes Federation). (2014). Available from: http://www.idf.org/worlddiabetesday/toolkit/gp/facts-figures
2. WHO (World Health Organization). (2014). Available from: http://www.who.int/mediacentre/factsheets/fs312/en/
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care (2013) 36:67–74.10.2337/dc13-S067
4. Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet (2012) 379:2279–90.10.1016/S0140-6736(12)60283-9
5. Thondre PS. Food-based ingredients to modulate blood glucose. Adv Food Nutr Res (2013) 70:181–227.10.1016/B978-0-12-416555-7.00005-923722097
6. Kwon Y-I, Apostolidis E, Shetty K. Inhibitory potential of wine and tea against alpha-amylase and alpha-glucosidase for management of hyperglycemia linked to type 2 diabetes. J Food Biochem (2008) 32:15–31.10.1002/bab.110524033596
7. Apostolidis E, Lee CM. In vitro potential of Ascophyllum nodosum phenolic antioxidant- mediated alpha- glucosidase and alpha- amylase. J Food Sci (2010) 75:H97–102.10.1111/j.1750-3841.2010.01544.x20492300
8. Friedmann M, Kim S-Y, Lee S-J, Han G-P, Han JS, Lee K-R, et al. Distribution of catechins, theaflavins, caffeine, and theobromin in 77 teas consumed in the United States. J Food Sci (2005) 70:C550–8.10.1111/j.1365-2621.2005.tb08304.x
9. Hanefeld M. Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes. Cardiovasc Diabetol (2007) 6:20–30.10.1186/1475-2840-6-2017697384
10. Preedy VR. Tea in Health and Disease Prevention. London, UK: Elsevier (2013).
11. Del Rio D, Stewart AJ, Mullen W, Burns J, Lean MEJ, Brighenti F, et al. HPLC-MS anaylsis of phenolic compounds and purine alkaloids in green and black tea. J Agric Food Chem (2004) 52:2807–15.10.1021/jf035484815137818
12. Kumar S, Narwal S, Kumar V, Prakash O. Alpha-glucosidase inhibitors from plants: a natural approach to treat diabetes. Pharmacogn Rev (2011) 5:19–29.10.4103/0973-7847.7909622096315
13. Shetty K, Curtis OF, Levin RE, Witkowsky R, Ang W. Prevention of vitrification associated with in vitro shoot culture of oregano (Origanum vulgare) by Pseudomonas spp. J Plant Physiology (1995) 147:447–51.10.1016/S0176-1617(11)82181-4
14. Worthington Enzyme Manual. (2014). Available from: http://worthington-biochem.com/AA/assay.html
15. Apostolidis E, Li L, Lee CM, Seeram NP. In vitro evaluation of phenolic- enriched maple syrup extracts for inhibition of carbohydrate hydrolyzing enzymes relevant to type 2 diabetes management. J Funct Foods (2011) 3:100–6.10.1016/j.jff.2011.03.003
16. Kwon Y, Apostolidis E, Shetty K. In vitro studies of eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant to type 2 diabetes and hypertension. Bioresour Technol (2008) 99:2981–8.10.1016/j.biortech.2007.06.03517706416
17. Apostolidis E, Li L, Kang B, Lee C, Seeram N. Seasonal influence on phenolic- mediated antihyperglycemic properties of Canadian sugar and red maple leaves using in vitro assay models. Food Sci Biotechnol (2012) 21:1–8.10.1007/s10068-012-0098-x
18. Pinto M, Kwon Y-I, Apostolidis E, Lajolo FM, Genovse MI, Shetty K. Functionality of bioactive compounds in Brazilian strawberry (Fragaria X ananassa Duch.) cultivars: evaluation of hyperglycemia and hypertension potential using in vitro models. J Agric Food Chem (2008) 56:4386–92.10.1021/jf073275818522404
19. Bischoff H, Puls W, Krause HP, Schutt H, Thomas G. Pharmacological properties of the novel glucosidase inhibitors BAY M 1099 (miglitol) and BAY O 1248. Diabetes Res Clin Pract (1985) (Suppl 1):S53.
20. Kang B-H, Racicot K, Pilkenton SJ, Apostolidis E. Evaluation of the in vitro anti-hyperglycemic effect of Cinnamomum cassia derived phenolic phytochemicals, via carbohydrate hydrolyzing enzyme inhibition. Plant Foods Hum Nutr (2014) 69:155–60.10.1007/s11130-014-0415-z24706251
21. Kang B, Racicot K, Pilkenton S, Apostolidis E. In vitro evaluation of blueberry powder of the management of type-2 diabetes and identification of responsible bioactive components. IFT 2014 Annual Meeting. New Orleans, LA (2014).